E. Papp

发表

Discovery of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (pamapimod) and 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as orally bioavailable and highly selective inhibitors

B. Graves, A. Kuglstatter, M. Stahl, 2011, Journal of medicinal chemistry.

Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase.

D. Rotstein, C. Ramesha, M. Browner, 2006, Journal of medicinal chemistry.

Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases alpha and beta.

C. Bach, E. Papp, M. S. Chen, 1993, Biochemistry.

Characterization of human type I and type II IMP dehydrogenases.

Y. Natsumeda, E. Papp, J. Wu, 1993, The Journal of biological chemistry.

Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.

D. Swinney, D. Shaw, J. Barnett, 2007, Biochemistry.

3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead.

A. Kuglstatter, M. Stahl, D. Swinney, 2011, Bioorganic & medicinal chemistry letters.

A fluorescence resonance energy transfer-based binding assay for characterizing kinase inhibitors: important role for C-terminal biotin tagging of the kinase.

J. M. Bradshaw, D. Shaw, E. Papp, 2009, Analytical biochemistry.

Molecular catalysis in liquid multiphase systems

F. Joó, E. Papp, Á. Kathó, 1998 .

Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.

Michelle Browner, Stephen D Warren, Eva Papp, 2003, Journal of medicinal chemistry.

Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity

K. Dabbagh, A. Manning, S. Peng, 2008, Journal of Pharmacology and Experimental Therapeutics.

Catalysis of redox isomerization of allylic alcohols by [RuClCp(mPTA)2](OSO2CF3)2 and [RuCp(mPTA)2(OH2-κO)](OSO2CF3)3·(H2O)(C4H10O)0.5. Unusual influence of the pH and interaction of phosphate with catalyst on the reaction rate

M. Serrano-Ruiz, F. Joó, A. Romerosa, 2010 .

Modification of Biomembranes by Catalytic Hydrogenation

F. Joó, E. Papp, L. Nádasdi, 1995 .

Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid.

R. C. Hawley, B. Devens, C. González, 1996, Journal of medicinal chemistry.

Rationally designed inhibitors of inosine monophosphate dehydrogenase.

K. Straub, E. Papp, J. Wu, 1997, Journal of medicinal chemistry.

Molecular Mechanism of the Syk Activation Switch*

Emily K. Tsang, J. M. Bradshaw, A. M. Giannetti, 2008, Journal of Biological Chemistry.

Title Page: Pamapimod, A Novel p38 MAP Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity

K. Dabbagh, A. Manning, Brian R. Wong, 2008 .

Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes

A. Kuglstatter, D. Shaw, J. Barnett, 2009, Chemical biology & drug design.

Multiple Deuteration of Water-Soluble Olefinic Acids with a [Pd(Alizarin Monosulfonate)2] Catalyst

I. Bányai, F. Joó, E. Papp, 2000 .